Back to Stakeholders
University of California Davis
United States
3 Trials
The Institute for Psychedelics and Neurotherapeutics (IPN) at UC Davis explores the neuroscience of psychedelics. Under the lead of David Olson, the team conducts high-impact interdisciplinary psychedelic science using modern neurobiology and chemistry tools. Contributions by the group include discovering that psychedelics promote neural plasticity, developing a biosensor for measuring hallucinogenic potential, and designing non-hallucinogenic psychedelic analogues with therapeutic potential.
Academic Research
0 papersPublished Papers
0
Trial Involvement
3
Distinct Focus Topics
0
Latest Publication
Unknown
Quick Facts
- Type
- academic
- HQ
- United States
- Website
- Visit